Here are some of the biggest patent myths founders believe — and a practical, startup-friendly IP strategy tied to business ...

However, I think a few stocks could be pretty close to being the kinds of investments you can set and forget. If you want ...

FOSHAN, GUANGDONG, CHINA, January 13, 2026 /EINPresswire.com/ -- In an era marked by rapid urbanization, rising ...

The US Patent and Trademark Office has partially ruled against solar manufacturer Maxeon in several claims against Canadian ...

Canada is the first country that is preparing to approve lower-cost generic weight loss drugs. Mr. Funk was the managing ...

David McCombs and Jonathan Bowser of Haynes Boone examine a recent Federal Circuit decision holding that IPR estoppel does ...

Across the country, federally funded science has spawned thousands of world-changing inventions, new companies, and millions ...

On Tuesday afternoon, the U.S. House of Representatives Ways and Means Committee's Subcommittee on Trade convened a hearing ...

Details of a settlement between Drake and DMACC reveal new rules for how the letter “D” can be used, ending more than a year ...

USPTO Director Squires’s 2025 policies encourage more use of evidence-based SMEDs to challenge patent rejections, especially ...

A new study published in the Strategic Management Journal sheds light on how multinational firms make strategic decisions ...

U.S. Patent No. 12,329,781 relates to Minovia’s proprietary mitochondrial augmentation technology for the treatment of renal diseases, including renal tubulopathy, kidney insufficiency, and chronic ...